Title:
NOVEL IONIZABLE LIPID FOR NUCLEIC ACID DELIVERY, AND LNP COMPOSITION AND VACCINE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/143600
Kind Code:
A1
Abstract:
The present invention provides a novel cationic lipid, a lipid nanoparticle, and a nucleic acid vaccine. According to the present invention, a specific cationic lipid is selected to prepare a lipid nanoparticle mRNA vaccine, and the lipid nanoparticle mRNA vaccine is found to have better in-vitro stability and immunogenicity as compared with the prior art.
More Like This:
Inventors:
YAN ZHIHONG (CN)
WANG HAOMENG (CN)
LI JIN (CN)
YUAN JINBO (CN)
LIU JIAN (CN)
YU XUEFENG (CN)
QIU DONGXU (CN)
ZHU TAO (CN)
WANG HAOMENG (CN)
LI JIN (CN)
YUAN JINBO (CN)
LIU JIAN (CN)
YU XUEFENG (CN)
QIU DONGXU (CN)
ZHU TAO (CN)
Application Number:
PCT/CN2023/073789
Publication Date:
August 03, 2023
Filing Date:
January 30, 2023
Export Citation:
Assignee:
CANSINO BIOLOGICS INC (CN)
International Classes:
A61K8/14; C07C217/08; A61K9/50; A61K39/145; A61P31/00; A61P31/12; C07C215/14; C07C219/06; C07C233/36; C07C255/24
Domestic Patent References:
WO2021055835A1 | 2021-03-25 | |||
WO2021159040A2 | 2021-08-12 | |||
WO2021204175A1 | 2021-10-14 |
Foreign References:
CN114149337A | 2022-03-08 | |||
CN114404584A | 2022-04-29 | |||
CN110352071A | 2019-10-18 | |||
US20180303925A1 | 2018-10-25 | |||
US20190274968A1 | 2019-09-12 | |||
CN113402405A | 2021-09-17 |
Attorney, Agent or Firm:
BEIJING LINKTEC IP LAW FIRM (SPECIAL GENERAL PARTNERSHIP) (CN)
Download PDF: